People Briefs: Louis Jacques To Leave CMS; FDA, MHRA Appointments
This article was originally published in The Gray Sheet
Executive Summary
Louis Jacques, who directs CMS’ coverage office, will leave the agency at the end of the month. FDA appoints acting deputy chief scientist. The U.K. Medicines and Healthcare products Regulatory Agency names clinical director of medical devices. More people briefs.
You may also be interested in...
People Briefs: FDA Turnover; Appointments At Boston Scientific, Dysis Medical
FDA Chief Scientist Jesse Goodman leaves agency. New FDA deputy commissioner for global regulatory operations and policy appointed. Boston Scientific names new chief medical officer. More people briefs.
Final Coverage-With-Evidence-Development Guidance Delayed By CMS Staff Cuts
The CMS coverage and analysis group has had to divert its attention from finishing a CED guidance to finalizing proposed changes to the process for awarding Medicare coverage for IDE trials, primarily due to staff cuts, says Louis Jacques, who heads the group.
FDA-CMS Parallel Review Saves Time, Clinical Trial Costs, Participant Says
Exact Sciences, one of the first companies to volunteer for a pilot program launched in 2011 testing FDA-CMS parallel review, says its experience with the process so far is very positive. Agency officials are planning to review experiences with the program to make improvements.